Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients

NCT01258712 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG: Tocilizumab + methotrexate(MTX)
DRUG: Tocilizumab placebo + methotrexate(MTX)

Sponsor

Chugai Pharma Taiwan